MedTrace Logo

New Stage 1 Formula on Gut Comfort and Gut Health

NCT02406937 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2016-10-10

Study results available
· View outcomes & findings →

Summary

180 qualified subjects aged from 7 days to 90 days will be enrolled with the 144 completed in study (allowing for a 20% drop-out rate). Subjects will be randomly assigned into 3 groups, including breast feeding, commercial and new formula group. Study intervention is 12 weeks.

Conditions

  • Health Behavior

Interventions

DIETARY_SUPPLEMENT

Oral intake of Feihe New Formula

Oral intake of Feihe New Formula

DIETARY_SUPPLEMENT

Oral intake of Feihe Stage 1 Formula

Oral intake of Feihe Stage 1 Formula

DIETARY_SUPPLEMENT

Breast Feeding

Oral intake of breast milk

Sponsors & Collaborators

  • Heilongjiang Feihe Dairy Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Jiancun Pan · Heilongjiang Feihe Dairy Co. Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Days
Max Age
90 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02406937 on ClinicalTrials.gov